Blog

It has been an extremely transformative year for KCAS in 2022. As we approach the beginning of 2023, Dom and John take a moment during episode #63 to look back at all the changes and evolutionary growth that has transpired around the organization (and around …

Podcast Eps #63: “A Look Back at 2022 While Looking Ahead to 2023” Read More »

Cell and Gene Therapies (CGTs) has an estimated market size value in 2022 of USD 8.22 billion and a revenue forecast in 2030 of USD 24.5 billion. This is a CAGR (compound annual growth rate) of 14.6% from 2022 to 2030. Needless to say, the …

Is GLP Bioanalysis needed to support your Cell and Gene Therapy GLP Tox Studies? Read More »

Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose formulation analysis results for your GLP studies are delivered on time. At KCAS, our scientific expertise allows us to develop methods that …

Dose Formulation Analysis Services from KCAS Read More »

There has been a virtual explosion over the last few years of a much more systematic acceptance of cell and gene therapy approaches to therapeutics – primarily in the cancer space with CAR T cell therapy. A key focus of cell therapy and gene therapy …

The Role of Flow Cytometry in Cell & Gene Therapy Research Read More »

Special guests John Bucksath, CEO of KCAS in Olathe, KS and Marc Essodaigui, General Manager of Active Biomarkers in Lyon, France, join Dom and John this week as they introduce our listeners to Active Biomarkers - the most recent acquisition of KCAS in the European …

Podcast Eps #62: “An Introduction to Active Biomarkers w/ Special Guests John Bucksath & Marc Essodaigui” Read More »

The European Bioanalysis Forum Open Symposium is a premier European forum for experts to meet and discuss bioanalysis and biomarker topics, similar to the WRIB event held in the United States.  EBF is an organization for European companies to discuss the regulations and guidance that …

KCAS will be attending, exhibiting, and presenting in Barcelona next week at the EBF open symposium with Flowmetric and Active Biomarkers Read More »